Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • imendez
    Junior Member
    • Mar 2016
    • 5

    #1

    One amplicon sequencing in Illumina

    Dear all!

    I want to sequence only one amplicon using Illumina platforms (I know that the deep is going to be crazy). I have very little experience on using this kind of platforms. Does anyone have experience on doing this? Does anyone know with protocol should I follow? Any hints and advice would be appreciated.

    Thanks!
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    Why did you post this in the Ion Torrent section then?

    Why do you need an NGS approach for this?

    Low diversity libraries (and this is the lowest possible diversity) are not the greatest fun to work with on Illumina platforms.

    Comment

    • NextGenSeq
      Senior Member
      • Apr 2009
      • 482

      #3
      If he's trying to detect extremely low amounts of a mutant it may make sense.

      I think the only way to do this is to amplify the region of interest with several sets of primers which give varying lengths of amplicons. It's not a single amplicon then though.

      Comment

      • thermophile
        Senior Member
        • Apr 2015
        • 243

        #4
        Single amplicon-as in 16S? Regardless, the primer design template from this paper should work well for any target gene (check for hairpins, check seq temp, etc). Plan on running a lot of phiX and underclustering

        http://aem.asm.org/content/79/17/511...0-b631ab573369
        Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

        Comment

        • lxkx
          Junior Member
          • Oct 2013
          • 2

          #5
          If you are doing one amplicon and not plan to do it again. It is probably easier to find someone around and spike in your sample with their run.

          The 16s protocol is a good reference if you want to build your own design, at least that is where I started. Low diversity is not an issue at all on Miseq. I have been doing 2-3 amplicons for my project frequently.

          Comment

          • jtotheulie
            Member
            • May 2016
            • 12

            #6
            If I have 16s, 18s, and its amplicons from 170 different samples and I want to do deep sequencing on MiSeq, what would be the best way to go about this?

            I understand that MiSeq has an easier time sequencing low diversity libraries with V3 kit.

            I want this to be cheap as possible.

            How should I barcode and lib prep the samples.

            How should I barcode and lip prep samples if I find they are at a low quant.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 02:55 AM
            0 responses
            4 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            10 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Working...